MedicineEnvironmental Science

Tommaso Lupia, S. Scabini, S. Mornese Pinna, G. di Perri, F. D. De Rosa, S. Corcione

2020.3.7Journal of Global Antimicrobial Resistance

DOI: 10.1016/j.jgar.2020.02.021

tlooto Summary

A novel Betacoronavirus (2019-nCoV; SARS-CoV-2) was recognised and has rapidly spread across continents and high rate of radiological and clinically suspicious pneumonia were reported in the reviewed cohorts of patients.

Abstract

Highlights • In December 2019, a novel Betacoronavirus (2019-nCoV; SARS-CoV-2) was recognised and has rapidly spread across continents.• 71 333 cases (17 February 2020) have been reported among 29 countries on the four main continents with mortality of ∼2%.• Fever with respiratory symptoms (e.g. cough, dyspnoea) are the first signs of the disease (COVID-19).• High rate of radiological and clinically suspicious pneumonia were reported in the reviewed cohorts of patients.• Risk of bacterial superinfection and empirical antibiotic coverage must be considered.

Citation format

LUPIA, Tommaso, et al. 2019 novel coronavirus (2019-ncov) outbreak: A new challenge. Journal of Global Antimicrobial Resistance, 2020, 21: 22–27.